WHO publishes pricing policy guideline to improve affordable access to medicines
On 28 September this year, the World Health Organization published a guideline on pricing policy with the aim to help countries contain drug prices and ensure they remain affordable for all. This is a crucial aspect of the progressive realisation of Universal Health Coverage. In WHO's own terms:
Unaffordable prices can be one of the biggest barriers to access to pharmaceutical products. A new WHO guideline for countries on managing pharmaceutical prices aims to help governments overcome this barrier and better address national public health needs.
According to WHO's analysis on the cost drivers of attaining the health targets across the SDGs (or SDG Health Price Tag) drugs and medical devices come third after Health workforce and Infrastructure. They represent 16% of the total price tag (see attached file for more details).
This new guideline will cover ten pricing policy approaches, which the UN Health Agency detailed in a comprehensive statement: Click here.